Romulus Brazzell

Romulus Brazzell

Chief Tech/Sci/R&D Officer at KALA BIO, INC.

Net worth: 436 $ as of 2026-06-29

73 year
Health Technology
Consumer Services
Finance

Profile

Romulus Kim Brazzell is currently Director at Mimetogen Pharmaceuticals, Inc. since 2024 and Chief Medical Officer, Head-Research & Development at Kala Bio, Inc. since 2021.
Former positions include Associate Director-Research & Development at Alcon Laboratories, Inc. from 1990 to 1991; Executive VP-Medical & Scientific Affairs at Inspire Pharmaceuticals, Inc. from 2010 to 2011; Senior Vice President-US Research & Development at Novartis Ophthalmics, Inc. from 2000 to 2004; Chief Medical Officer at Mimetogen Pharmaceuticals, Inc. from 2012 to 2015; Vice President-Research & Development at Ciba Vision Ophthalmics Co. from 1996 to 2000; and Principal at Acuity Advisors LLC from 2014 to 2018.
Education includes undergraduate and doctorate degrees from the University of Kentucky.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-12-28 252 ( 0% ) 436 $ 2026-06-29

Romulus Brazzell active positions

CompaniesPositionStart
KALA BIO, INC. Chief Tech/Sci/R&D Officer 2013-01-31
Director/Board Member 2023-12-31

Former positions of Romulus Brazzell

CompaniesPositionEnd
Corporate Officer/Principal 2018-06-30
Chief Tech/Sci/R&D Officer 2015-11-30
Chief Tech/Sci/R&D Officer 2010-12-31
Chief Tech/Sci/R&D Officer 2003-12-31
Ciba Vision Ophthalmics Co.
Chief Tech/Sci/R&D Officer 1999-12-31
See the detail of Romulus Brazzell's experience

Training of Romulus Brazzell

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

57

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Ciba Vision Ophthalmics Co.

Finance

  1. Stock Market
  2. Insiders
  3. Romulus Brazzell